Media Coverage
The work done by Northwestern University Feinberg School of Medicine faculty members (and even some students) is regularly highlighted in newspapers, online media outlets and more. Below you’ll find links to articles and videos of Feinberg in the news.
-
Reuters
–
VA may top other hospitals in quality but not patient satisfaction
Veterans Affairs (VA) hospitals in the U.S. may deliver higher quality care than other medical centers but still get lower marks on patient satisfaction, a new study suggests. “The VA certainly looks good on many of these measures, but they definitely have room for improvement regarding the patient experience,” said senior study author Dr. Karl Bilimoria, director of the Surgical Outcomes and Quality Improvement Center at Northwestern University Feinberg School of Medicine in Chicago. “Patients at VA hospitals were less likely to recommend VA hospitals to friends or family than patients at non-VA hospitals,” Bilimoria said.
-
HealthDay
–
Is It Wise to Take a Steroid for a Sore Throat?
Side effects from steroids are also possible but rare, according to Dr. Jeffrey Linder of Northwestern University School of Medicine in Chicago. “They include increased blood pressure, increased blood sugar, fluid retention,” he said. “They could be significant for people at risk for diabetes complications and at risk for cardiovascular disease,” said Linder, chief of the division of general internal medicine and geriatrics. Linder, who wasn’t involved in the research, noted that only about one-third of the steroid takers in the study actually got better within two days. “This is a well-done study and again, it is negative. I don’t think patients go to the doctor expecting to get a treatment that is only going to give them a 1 in 3 chance of complete resolution of their symptoms within two days,” he said.
-
CNN
–
Should you take statins? Two guidelines offer different answers
The guidelines “highlight many, many important similarities much more than it highlights some small differences,” said Dr. Don Lloyd-Jones, a spokesperson for the AHA and a professor of preventive medicine at Northwestern University Feinberg School of Medicine. “Both guidelines start with the same concepts,” he said. “The difference is how they look at the evidence.” “We’ve seen a number of groups in which (the risk calculator) performs extremely well,” said the Heart Association’s Lloyd-Jones. Lloyd-Jones said that the current risk estimator was “a huge step forward” in that it accounts for women and African Americans, who have often been overlooked in large-scale health surveys. The 7.5% threshold used by the AHA is based heavily on clinical trial data, he said. “These risk scores were never intended to be perfect,” Lloyd-Jones said. “They’re there to start a conversation, not to write a prescription.” “The purpose of the ACC/AHA, the purpose of USPSTF is not to create a healthy pharmaceutical industry. It’s to create better care for our patients,” Lloyd-Jones said.
-
WebMD
–
Stem Cells for Knees: Promising Treatment or Hoax?
Kathleen Doheny”There is still not enough evidence to suggest this should be routine treatment for knee early osteoarthritis,” says Wellington Hsu, MD, the Clifford C. Raisbeck professor of orthopedic surgery at Northwestern University Feinberg School of Medicine. Even so, he says, ”there is very little damage you are going to do with an injection to the knee. I think stem cells appear to be safe in orthopedic applications. “There is, of course, the risk that an investment of a couple thousand dollars will do nothing. But Hsu says that ”you are not going to find the catastrophic cases that will shut down a clinic [as may occur for other body parts].’ For people who have knee arthritis, the most invasive treatment is total knee replacement, Hsu says. The FDA requires donor cells and tissues to be tested for communicable diseases. There is no consensus on which source is best, but most doctors use stem cells from fat, Hsu says.
-
HealthDay
–
‘Electric Cap’ Might Help Fight a Deadly Brain Tumor
But in the study, more than twice as many patients were alive five years after getting it, plus the usual chemotherapy, than those given just the chemo — 13 percent versus 5 percent. “It’s out of the box” in terms of how cancer is usually treated, and many doctors don’t understand it or think it can help, said Dr. Roger Stupp, a brain tumor expert at Northwestern University in Chicago. He led the company-sponsored study while previously at University Hospital Zurich in Switzerland, and gave results Sunday at an American Association for Cancer Research meeting in Washington.
-
U.S. News & World Report
–
A ‘Sci-Fi’ Cancer Therapy Fights Brain Tumors, Study Finds
But in the study, more than twice as many patients were alive five years after getting it, plus the usual chemotherapy, than those given just the chemo — 13 percent versus 5 percent. “It’s out of the box” in terms of how cancer is usually treated, and many doctors don’t understand it or think it can help, said Dr. Roger Stupp, a brain tumor expert at Northwestern University in Chicago. He led the company-sponsored study while previously at University Hospital Zurich in Switzerland, and gave results Sunday at an American Association for Cancer Research meeting in Washington.
-
The Washington Post
–
A ‘Sci-Fi’ Cancer Therapy Fights Brain Tumors, Study Finds
But in the study, more than twice as many patients were alive five years after getting it, plus the usual chemotherapy, than those given just the chemo — 13 percent versus 5 percent. “It’s out of the box” in terms of how cancer is usually treated, and many doctors don’t understand it or think it can help, said Dr. Roger Stupp, a brain tumor expert at Northwestern University in Chicago. He led the company-sponsored study while previously at University Hospital Zurich in Switzerland, and gave results Sunday at an American Association for Cancer Research meeting in Washington.
-
The New York Times
–
A ‘Sci-Fi’ Cancer Therapy Fights Brain Tumors, Study Finds
But in the study, more than twice as many patients were alive five years after getting it, plus the usual chemotherapy, than those given just the chemo — 13 percent versus 5 percent. “It’s out of the box” in terms of how cancer is usually treated, and many doctors don’t understand it or think it can help, said Dr. Roger Stupp, a brain tumor expert at Northwestern University in Chicago. He led the company-sponsored study while previously at University Hospital Zurich in Switzerland, and gave results Sunday at an American Association for Cancer Research meeting in Washington.
-
Chicago Tribune
–
A ‘sci-fi’ cancer therapy fights brain tumors, study finds
But in the study, more than twice as many patients were alive five years after getting it, plus the usual chemotherapy, than those given just the chemo — 13 percent versus 5 percent. “It’s out of the box” in terms of how cancer is usually treated, and many doctors don’t understand it or think it can help, said Dr. Roger Stupp, a brain tumor expert at Northwestern University in Chicago. He led the company-sponsored study while previously at University Hospital Zurich in Switzerland, and gave results Sunday at an American Association for Cancer Research meeting in Washington.
-
The Associated Press
–
A ‘sci-fi’ cancer therapy fights brain tumors, study finds
But in the study, more than twice as many patients were alive five years after getting it, plus the usual chemotherapy, than those given just the chemo — 13 percent versus 5 percent. “It’s out of the box” in terms of how cancer is usually treated, and many doctors don’t understand it or think it can help, said Dr. Roger Stupp, a brain tumor expert at Northwestern University in Chicago. He led the company-sponsored study while previously at University Hospital Zurich in Switzerland, and gave results Sunday at an American Association for Cancer Research meeting in Washington.
